Greenwich Lifesciences Inc. recently announced a change in its certifying accountants. On July 19, 2025, the company's audit committee decided to dismiss RBSM LLP as the independent registered public accounting firm and appointed MaloneBailey LLP to audit its consolidated financial statements for the year ending December 31, 2025. RBSM's reports on the company's financial statements for 2023 and 2024 did not contain any adverse opinions or disclaimers. However, the company did note material weaknesses in its internal control over financial reporting during those years. No disagreements or reportable events were cited in connection with RBSM's dismissal. The transition to MaloneBailey is effective immediately.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.